Home » Newsletters » BioWorld Science

BioWorld Science

July 14, 1997

View Archived Issues

TPO binding dynamics determined in vivo in mice

Newer valpromide analogues for treating epilepsy

Lp(a)-dependent actions of LMWH

CMV infection implicated in atherosclerosis

Low cholesterol levels contribute to increased mortality

Beneficial cardiovascular effects of garlic demonstrated in humans

Antiulcer drug shows bactericidal activity against H. pylori

Takeda's fumagillin analogue for microsporidial infections in AIDS patients

BMS compound excellent candidate for development in HBV

Mylan, Purepac and ESI Lederle report FDA generic approvals

U.S. patent covers obesity gene discovered by Millennium

U.S. patent covers protease inhibitors from Sparta and Univ. of Pennsylvania

Ergo Science's Ergoset enters phase II/III trials in obesity

Vical and Pasteur Merieux Connaught initiate phase I malaria trial

Knoll receives FDA approval to market Mavik for new indication

Allergan reports agents with retinoid-like activity

British Biotech: FY 1996/97 highlights

British Biotech describes orally active MMP/TNF inhibitors

UCLA isolates new antimicrobial agents

Novartis reports compounds with affinity for mGluR

5-HT1B antagonists from SmithKline Beecham

Novel NSAID for rheumatoid arthritis characterized by Fujisawa

Radiosensitizing and tumor-imaging effects of KADTF

More enediyne compounds from Sanwa Kagaku and Nagoya University

Gamma-pyrones for osteoporosis isolated from plant extract by Sumitomo Metal

R&D pipeline progress at Asta Medica

More on aspirin in cardiovascular medicine

Profile of a new formulation of eperisone hydrochloride

Novartis' R&D pipeline

Fujisawa reduces stake in Fujisawa Synthelabo

Mylan antianxiety/antipsychotic generic approved by FDA

FDA approves antibacterial generic from Mylan